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Modular synthesis and transition metal-free
alkynylation/alkenylation of Castagnoli–Cushman-
derived N,O- and N,S-heterocyclic vinyl chlorides†
Timothy K. Beng, * Abdikani Omar Farah and Victoria Shearer
A modular and functional group-tolerant protocol for the transition metal-free coupling of novel N,O- and
N,S-heterocyclic vinyl chlorides with terminal acetylenes and styrenes has been developed, leading to the
epimerization-free synthesis of fully carbofunctionalized dihydro-1,4-oxazines/thiazines. Bicyclic
morpholines have also been prepared through the interrogation of newly synthesized cross-conjugated
dienes in Diels–Alder reactions. The use of environmentally benign reaction media endows the current
strategy with a practical advantage.
Introduction
Partially and fully reduced 1,4-oxazines and thiazines (examples
of which are depicted in Fig. 1) constitute the core of several
alkaloid natural products, corrosion inhibitors, optical bleach-
ing agents, textile dying agents, fruit preservation agents,
ligands and pharmaceuticals.1 The biological relevance of these
heterocycles as well as their architectural complexity continue
to endear them to the medicinal and synthesis communities,
thus, inspiring the development of increasingly more cost-
effective and environmentally friendly strategies for their
construction, peripheral functionalization, and evaluation of
structure–activity relationships (i.e., S.A.R.). However, designing
selective, efficient, cost-effective, and modular strategies for
accessing N,O- and N,S-heterocycles can be quite daunting
mainly due to conformational constraints and their insatiable
appetite for ring opening. These challenges notwithstanding,
several transition metal-catalyzed strategies for accessing C-
substituted dihydro-1,4-oxazines and 1,4-thiazines have
emerged, including those employed by Katukojvala2 (using
diazoenals), Saa3 (using catalytic ruthenium carbenes derived
from alkynals and alkynones), Bode4 (using SnAP and SLAP
reagents), Tiecco5 (using vinyl selenones), and Carreira6 (using
spirocyclic 3-oxetanones).
Alkynes are frequently used as building blocks in organic
synthesis and as catalysts in asymmetric catalysis owing to their
rich reactivity proles.7 Since the seminal work of Sonogashira
and co-workers,8 Sonogashira-type cross-couplings have
become one of the most reliable methods for the construction
of internal alkynes with differential substitution.9 Recognizing
the merits of the Castagnoli–Cushman reaction (e.g., the use of
feedstock chemicals such as amines, aldehydes and cyclic
anhydrides to readily access nonplanar sp3-enriched core
structures bearing vicinal stereocenters), our group10 as well as
that of Krasavin11 previously disclosed that lactams of type 3 are
obtainable from imines such as 1 and cyclic anhydrides of type
2 (Fig. 2, top). Desiring a modular and operationally simple
approach to alkynylated dihydro-1,4-oxazines and thiazines, it
was surmised that transition metal-free late-stage coupling of
densely populated precursors such as 4 with terminal alkynes
offered an excellent starting point (Fig. 2). The appendage of an
alkynyl motif to the skeleton of a cyclic enamine (see 5) offers
several advantages for the synthesis of alkaloids and nitrogen-
Fig. 1 Examples of bioactive 1,4-oxazine and thiazine derivatives.
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containing pharmaceuticals. As has been previously demon-
strated by Toste12 and Occhiato,13 alkyne-substituted enamines
may be engaged in Conia-ene and carboauration-type trans-
formations. Meanwhile, the synthesis of conjugated dienes of
type 6 via a Heck-type coupling protocol could pave the way for
the construction of polycyclic morpholines.14 We were not
oblivious to the challenges that belie such transformations
seeing as vinyl chlorides such as 4 seldom feature in mild cross-
couplings, even under transition metal-catalyzed conditions.
This is presumably due to challenges associated with an
extremely slow oxidative addition step.15 The successful imple-
mentation of the planned strategy would also hinge on our
ability to negate incessant ring-opening events that are typically
associated with morpholines and thiomorpholines.16 We were
also keen on accessing 4 upon recognizing that it retains latent
functionality throughout the periphery of the heterocycles that
could facilitate further manipulation. For example, the enal
subunit may be engaged in conventional olenation/cyclization
technologies to arrive at intermediates of type 7. Additionally,
the C–C double bond resident in 4 could pave the way for har-
nessing several reactivity modes, including hydroarylation,17
oxoamination,18 dioxygenation19 triuoromethylation,20 aziridi-
nation,21 pentannulation,22 and boration.23 Herein, detailed
efforts toward the elicitation of our ideals are described.
Results and discussion
We initiated studies toward the transition metal-free coupling
of N,O- and N,S-heterocyclic vinyl chlorides by attempting to
nd general Vilsmeier–Haack conditions for preparing
precursor 4. In the event, we found that under reaction condi-
tions analogous to those previously optimized on the more
stable piperidine system,24 morpholinones bearing electron-
rich-, electron-neutral- and electron-decient N-aryl
substituents as well as alkyl and benzyl substituents underwent
productive lactam-selective Vilsmeier–Haack functionalization
(Scheme 1). In all cases, satisfactory yields were obtained (see
4a1–4a18). As we have previously noted,24 the silica/Et3N system
employed in these studies for mild hydrolysis of the interme-
diate chloromethylene iminium salts is desirable given that the
use of conventional bases such as NaOH, KOH or NH4OAc led to
poor yields, undesirable epimerization, and ring-opened side
products.
The corresponding dihydro-1,4-thiazines have also been
prepared (Scheme 2). However, low temperatures and shorter
reaction times were required. The variable diastereomeric ratios
reported in these cases reect those of the lactam precursors
Fig. 2 Proposed plan for the transition metal-free functionalization of
N,O- and N,S-heterocyclic vinyl chlorides.
Scheme 1 Synthesis of N,O-heterocyclic vinyl chlorides.
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rather than epimerization during the Vilsmeier–Haack reaction.
The slight decrease in yields is a reection of the somewhat
fragile nature of the products.
With an assorted wardrobe of N,O- and N,S-heterocyclic vinyl
chlorides in hand, we next sought efficient conditions for
transition metal-free a-alkynylation. Despite the many merits of
transition metal-catalyzed coupling of inert substrates of this
class,24 one of our objectives was to avoid the drawbacks,
including toxicity, cost, need for substrate-dependent designer
ligands, and risk of product contamination. We also desired to
utilize a sustainable solvent as the reaction medium for the
alkynylation. Aer perusing the literature for some transition
metal-free conditions,25 we were pleased to nd that N,O-
heterocyclic vinyl chlorides of type 4a undergo efficient
alkynylation with triisopropylsilylacetylene to afford the prod-
ucts depicted in Scheme 3 (see 5a–g). These directing group-free
conditions employ hindered and non-nucleophilic lithium tet-
ramethylpiperidide (LiTMP) as the base and environmentally
benign 2-MeTHF26 as the reaction medium. Differentially
substituted N-aryl and N-alkyl vinyl chlorides have been
surveyed and satisfactory outcomes were obtained in most
cases. The ability to install a triisopropylsilyl motif bodes well
for further diversication since its robust yet removable
nature27 allows it to be employed as a terminal acetylene
surrogate. The direct coupling of 4a with inherently inert and
typically challenging alkyne coupling partners such as
Scheme 2 Synthesis of N,S-heterocyclic vinyl chlorides.
Scheme 3 Transition metal-free alkynylation of N,O- and N,S-
heterocyclic vinyl chlorides.
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cycloalkenyl, chloroalkyl, and aryl acetylenes proceeds satis-
factorily (see 5h–k). Congruent with 4a, the use of innately
fragile N,S-heterocyclic vinyl chlorides of type 4b leads to
productive alkynylation (see 5l–o).
Although the mechanistic underpinnings of the trans-
formation are still under investigation, our working hypothesis
is that homolytic cleavage of the C–Cl bond resident in 4a3
furnishes G, which reacts with the alkyne to generate vinyl
radical H. H can then undergo termination with the free chlo-
rine radical in solution to arrive at I. Finally, a base-promoted E2
reaction of newly formed vinyl chloride I affords the desired
coupling product (Fig. 3).
Our studies have revealed that N,O-heterocyclic vinyl chlo-
rides of type 4a are amenable to transition metal-free cross-
coupling with styrenes (Scheme 4). Electron-decient,
electron-rich, and electron-neutral styrenes couple satisfacto-
rily to afford these Diels–Alder-suitable cross-conjugated
dienes. The orthogonality of the coupling strategy is high-
lighted by observations that substrates bearing an aryl chloride
motif undergo site-selective coupling (see 6b–e). The coupling
presumably proceeds via a radical pathway.28 Although not
surprising, it is disappointing that N,S-heterocyclic vinyl chlo-
rides of type 4b are fragile under this tert-BuOK conditions and
undergo undesirable ring-opening.
As articulated previously, we were drawn toward vinyl chlo-
rides of type 4 aer recognizing that they harbor versatile
functional handles that could facilitate fragment-based
discovery. To elucidate this point, we have subjected
aldehyde-bearing chloroenaminol ether 4a9 to the catalytic
hydrogenation conditions described in Scheme 5. In the event,
reduction of the styrenyl double bond was accompanied by
hydrodeoxygenation of the aldehyde functionality and
concomitant dehalogenation, affording methyl-bearing
enamine 8 in high yield. This cascade reduction appears to be
general given that alkyne 5c reacts in similar fashion to afford
tris-alkylated dihydro-1,4-oxazine 9. The failure to reduce the
endocyclic C–C double bond speaks to the challenges associ-
ated with reducing a tetrasubstituted enamine.
Medicinal chemists are becoming increasingly keen on
escaping atland in view of exploring 3D-structural space.
Fig. 3 Tentative mechanism for transition metal-free alkynylation of
activated vinyl chlorides.
Scheme 4 Transition metal-free alkenylation of N,O-heterocyclic
vinyl chlorides.
Scheme 5 Cascade reduction of functionalized dihydro-1,4-oxazines.
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Accordingly, bicyclic morpholines are viewed as valued targets
for pharmaceutical companies. Pleasingly, Wittig olenation of
enals of type 4a followed by a room temperature normal
electron-demand Diels–Alder cycloaddition with tetracyano-
ethylene proceeds efficiently to afford oxazabicycles such as 7a
and 7b, which bear three contiguous tetrasubstituted sp3
carbons (Scheme 6). These mild reaction conditions are note-
worthy since they allow for the retention of the pharmaceuti-
cally pertinent a-chloroamino motif. Unambiguous
establishment of the relative conguration of 7a/b has not been
achieved at this point.
Of note, when the Diels–Alder reaction is performed at
slightly elevated temperatures, a cascade process ensues
whereby the cycloaddition is accompanied by 1,4-elimination
(see 10). A similar mode of reactivity is operative when diene 3a5
and bromomaleic anhydride are heated to 90 C, leading to the
formation of benzomorpholine 11 whose benzenoid portion is
highly functionalized.
Conclusions
In summary, chemoselective Vilsmeier–Haack functionalization
of morpholinonates and thiomorpholinonates has been success-
fully implemented, leading to the modular synthesis of N,O- and
N,S-heterocyclic vinyl chlorides. The versatility of these densely
populated organic chlorides has been amply demonstrated
through transition metal-free late-stage alkynylation and alkeny-
lation protocols, under environmentally benign conditions. Bicy-
clic and tricyclic morpholines have also been assembled through
the interrogation of cross-conjugated 1,3-dienes in Diels–Alder
reactions. The current work stands as an advance over existing
methodologies given that the construction of these versatile
intermediates can be achieved in modular step-economical,
directing/protecting group-free, high-yielding, and transition
metal-free fashions. The amenability of these highly functional-
ized intermediates to C–C bond forming transformations bodes
well for future late-stage assembly of complex morpholine/
thiomorpholine-bearing bioactive molecules.
Experimental
All experiments involving air and moisture sensitive reagents
were carried out under an inert atmosphere of nitrogen and
using freshly distilled solvents. Column chromatography was
performed on silica gel (230–400 mesh). Thin-layer chroma-
tography (TLC) was performed using Silicycle Siliaplate™ glass
backed plates (250 mm thickness, 60 Å porosity, F-254 indicator)
and visualized using UV (254 nm) or KMnO4 stain. Unless
otherwise indicated, 1H, 13C, and DEPT-135 NMR, and NOESY
spectra were acquired using CDCl3 solvent at room tempera-
ture. Chemical shis are quoted in parts per million (ppm).
HRMS-EI+ data were obtained using either electronspray ioni-
zation (ESI) or electron impact (EI) techniques. High-resolution
ESI was obtained on an LTQ-FT (ion trap; analyzed using
Excalibur). High resolution EI was obtained on an Autospec
(magnetic sector; analyzed using MassLynx).
General procedure A
Vilsmeier–Haack functionalization. To a solution of DMF
(40 mmol, 4 equiv.) in CH2Cl2 (50 mL) at 0 C was added
dropwise, phosphorus oxychloride (20 mmol, 2 equiv.). The
resulting pale yellowmixture was reuxed for 60 min. A solution
of the lactamoyl ester (10 mmol, 1 equiv.) in CH2Cl2 (50 mL) was
added slowly under reux. Aer complete addition of the lac-
tam, the mixture was cooled to room temperature (if 3a) or 0 C
(if 3b) and stirred for the indicated time period (TLC and LC-MS
monitoring was used to follow the extent of the reaction). Upon
completion, the mixture was poured into a large ask contain-
ing crushed ice. Aer stirring at room temperature for 60 min,
the layers were separated (the majority of the product stays in
the DCM layer). Powdered K2CO3 was added slowly to the
aqueous layer and the ask was swirled aer each addition
(Caution: it bubbles vigorously). The addition/swirling was
continued until persistent cloudiness was observed. The
neutralized/slightly basic mixture was extracted two times with
CH2Cl2. The combined organic layers (three in total, one before
and two aer addition of K2CO3) were washed with brine and
dried over Na2SO4 for 30 min. The mixture was ltered and
concentrated under reduced pressure to give the desired
product as an oily salt.
General procedure B
Transition metal-free alkynylation. To an oven-dried,
septum-capped 2-neck-round bottom ask equipped with
a stir bar, was added the chloroenal (0.5 mmol, 1.0 equiv.) in 2-
MeTHF (5 mL) under an argon atmosphere. The desired alkyne
Scheme 6 Synthesis of bicyclic and tricyclic morpholines.
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(1.2 equiv.) was added. Aer completely degassing the ask,
LiTMP (147.2 mg, 2 equiv.) was added. The mixture was then
stirred at room temperature for the desired length of time (as
indicated by TLC and LC-MS). Upon completion, the mixture
was quenched with methanol. The combined organics were
concentrated to 5 mL and directly subjected to ash chro-
matography on silica, pretreated with Et3N.
General procedure C
Transition metal-free alkenylation with styrenes. To a dried
Schlenk tube was transferred potassium tert-butoxide (56 mg,
2.0 equiv.) and 1,10-phenanthroline (7 mg, 15 mol%). The
sealed tube was evacuated and lled with argon three times. A
solution of vinyl chloride 4a (0.25 mmol) in 5 mL anhydrous 2-
MeTHF was added via syringe and the mixture was stirred for
several seconds at room temperature. The tube was placed in an
oil bath that was preheated to 90 C and it was stirred for 18 h
(GC-MS and TLCmonitoring). Upon completion of the reaction,
the mixture was cooled to room temperature and ltered
through a short silica plug and the silica was washed with ethyl
acetate. The organic solvents were evaporated under reduced
pressure and the product was puried by ash column chro-
matography on silica gel, pretreated with triethylamine.
Synthesis of N,O-heterocyclic vinyl chloride 4a1. Prepared in
10 mmol scale using general procedure A. Temp ¼ room
temperature, time ¼ 22 h, purication: ash chromatography
on silica (pretreated with 1% Et3N) eluting with hexane/EtOAc
(80 : 20). Yield ¼ 9.416 g, 74%. 1H NMR (400 MHz, chloro-
form-d) d 9.70 (s, 1H), 7.67 (d, J¼ 8.1 Hz, 2H), 7.40–7.22 (m, 2H),
6.88 (d, J ¼ 8.2 Hz, 2H), 6.63 (d, J ¼ 15.8 Hz, 1H), 6.21 (dd, J ¼
15.9, 6.5 Hz, 1H), 5.01 (s, 1H), 4.89 (d, J ¼ 6.5 Hz, 1H), 3.62 (s,
3H). 13C NMR (101 MHz, CDCl3) d 180.4, 167.7, 142.2, 138.5,
135.2, 134.1, 132.8, 131.5, 130.3, 128.8, 127.2, 122.4, 119.6, 91.8,
74.6, 62.6, 52.7. HRMS calc. for C21H17ClINO4, 508.9891, found
509.9899.
Note: all other N,O-heterocyclic vinyl chlorides depicted in
Scheme 1 were prepared as described above. Spectroscopic data
can be found in the ESI.†
Synthesis of N,S-heterocyclic vinyl chloride 4b1. Prepared
using general procedure A. Temp ¼ 23 C for 18 h. Purication:
ash chromatography on silica (pretreated with 1% Et3N)
eluting with hexane/EtOAc (80 : 20). Yield¼ 296.3 mg, 81%, oily
substance.1H NMR (400MHz, chloroform-d) d 9.81 (s, 1H), 7.44–
7.28 (m, 5H), 6.49 (dd, J ¼ 32.9, 15.7 Hz, 1H), 6.16 (dd, J ¼ 15.8,
6.8 Hz, 1H), 4.94 (ddd, J ¼ 6.9, 2.9, 1.1 Hz, 1H), 4.85 (p, J ¼
6.7 Hz, 1H), 3.88 (dd, J ¼ 2.8, 1.0 Hz, 1H), 3.71 (s, 3H), 1.42–1.16
(m, 6H). 13C NMR (101 MHz, CDCl3) d 185.5, 185.0, 169.4, 142.4,
135.6, 133.8, 132.7, 128.8, 128.7, 128.6, 128.5, 128.4, 126.9,
126.8, 126.4, 122.5, 102.5, 56.8, 56.4, 53.1, 52.9, 52.6, 47.9, 44.6,
22.3, 21.3, 20.7, 19.6. HRMS calc. for C18H20ClNO3S 365.0852,
found 365.0855.
Note: all other N,S-heterocyclic vinyl chlorides depicted in
Scheme 2 were prepared as described above. Spectroscopic data
can be found in the ESI.†
Synthesis of enyne 5a. Prepared in 0.5 mmol scale using
general procedure B. Purication: ash chromatography on
silica (pretreated with 1% Et3N) eluting with hexane/EtOAc
(95 : 5). Yield ¼ 221 mg, 79%, 95 : 5 dr. 1H NMR (400 MHz,
chloroform-d) d 9.68 (s, 1H), 7.41–7.22 (m, 6H), 7.15–7.06 (m,
2H), 6.89–6.78 (m, 2H), 6.56 (d, J ¼ 15.8 Hz, 1H), 6.27 (dd, J ¼
15.8, 7.7 Hz, 1H), 4.99 (d, J¼ 1.7 Hz, 1H), 4.73 (dt, J¼ 7.6, 1.4 Hz,
1H), 3.78 (t, J ¼ 3.3 Hz, 7H), 0.91 (d, J ¼ 4.3 Hz, 21H). 13C NMR
(101 MHz, CDCl3) d 180.60, 168.30, 158.60, 138.54, 136.50,
135.62, 133.9, 128.7, 128.5, 127.8, 126.9, 123.5, 114.3, 104.5,
95.2, 74.8, 62.4, 55.6, 52.8, 18.4, 11.0. HRMS calc. for
C33H41NO5Si, 559.2754, found 559.2759.
Note: all other enynes depicted in Scheme 3 were prepared as
described above. Spectroscopic data can be found in the ESI.†
Synthesis of diene 6a. Prepared in 0.25 mmol scale using
general procedure C. Purication: ash chromatography on
silica (pretreated with 1% Et3N) eluting with hexane/EtOAc
(80 : 20). Yield ¼ 103.8 mg, 83%, 95 : 5 dr. 1H NMR (400 MHz,
CDCl3) d 9.78 (s, 1H), 7.79 (d, J ¼ 14.2 Hz, 1H), 7.53–7.02 (m,
13H), 6.99 (d, J¼ 14.2 Hz, 1H), 6.73 (d, J¼ 12.5 Hz, 1H), 6.49 (dd,
J ¼ 12.6, 1.3 Hz, 1H), 5.08 (dd, J ¼ 5.8, 1.3 Hz, 1H), 4.78 (d, J ¼
1.3 Hz, 1H), 3.75 (s, 3H), 2.22 (s, 3H). 13C NMR (101MHz, CDCl3)
d 180.6, 180.5, 167.9, 138.6, 134.2, 129.6, 128.9, 128.8, 127.3,
127.2, 126.9, 126.6, 122.7, 122.4, 74.7, 74.7, 64.2, 63.9, 52.8, 52.8,
21.4. HRMS calc. for C30H26ClNO4, 499.1550, found 499.1555.
Note: all other dienes depicted in Scheme 4 were prepared as
described above. Spectroscopic data can be found in the ESI.†
Synthesis of enamine 8. To a 25 mL-round-bottomed ask
equipped with a magnetic stir bar was added EtOAc (5 mL) and
10% Pd/C (100 mg) at room temperature. A solution of chlor-
oenal 4a9 (113 mg, 0.25 mmol) in EtOAc (5 mL) was added. The
ask was degassed and placed under an inert atmosphere of
nitrogen. Aer complete addition of the chloroenal, the
nitrogen line was cut off. A balloon of H2 was attached and the
reaction mixture was stirred at room temperature. Aer
complete consumption (based on GC-MS and TLC monitoring),
the mixture was ltered through Celite and concentrated under
reduced pressure to afford the product as an oil. Purication:
ash chromatography on silica (pretreated with 1% Et3N)
eluting with hexane/EtOAc (85 : 15). Yield ¼ 90.2 mg, 89%,
95 : 5 dr. 1H NMR (400 MHz, chloroform-d) d 7.42–7.29 (m, 6H),
7.14–6.71 (m, 3H), 5.63 (s, 1H), 4.82 (d, J¼ 1.7 Hz, 1H), 4.46–4.35
(m, 1H), 3.45 (s, 3H), 2.97–2.76 (m, 2H), 2.15–2.00 (m, 5H). 13C
NMR (101MHz, CDCl3) d 169.1, 146.5, 140.7, 136.4, 132.1, 131.8,
131.5, 129.8, 128.7, 128.5, 128.4, 126.4, 125.6, 122.9, 117.4,
115.4, 110.7, 110.7, 102.0, 77.5, 77.2, 76.8, 75.3, 54.1, 51.9, 32.5,
31.0, 17.6. HRMS calc. for C22H22F3NO3, 405.1552, found
405.1557.
Note: enamine 9 was prepared as described above. Spectro-
scopic data can be found in the ESI.†
Synthesis of bicyclic morpholine 7a. Prepared in 0.50 mmol
scale using general procedure D. Purication: ash chroma-
tography on silica (pretreated with 1% Et3N) eluting with
hexane/EtOAc (85 : 15). Yield ¼ 264.0 mg, 88%, 90 : 10 dr. 1H
NMR (400 MHz, CDCl3) d 7.56–7.16 (m, 14H), 6.75 (d, J¼ 8.3 Hz,
1H), 6.29 (ddd, J ¼ 57.5, 15.9, 6.7 Hz, 3H), 5.83–5.76 (m, 1H),
5.13 (d, J¼ 1.5 Hz, 1H), 4.72 (d, J¼ 1.5 Hz, 1H), 3.91 (s, 3H), 3.87
(d, J ¼ 10.6 Hz, 1H), 2.23 (s, 3H). 13C NMR (101 MHz, CDCl3)
d 168.3, 166.9, 153.5, 153.1, 141.3, 137.1, 136.6, 134.6, 134.5,
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132.2, 129.9, 129.4, 129.2, 128.9, 128.6, 127.2, 126.8, 125.3,
118.8, 116.2, 114.8, 113.1, 112.7, 110.7, 86.6, 85.8, 67.2, 67.0,
54.0, 21.4. HRMS calc. for C35H26ClN5O3, 599.1724, found
599.1729.
Note: bicyclic morpholine 7b was prepared as described
above. Spectroscopic data can be found in the ESI.†
Synthesis of bicyclic morpholine 10. Prepared in 0.50 mmol
scale using general procedure D but the Diels–Alder reaction
was conducted at 60 C for 2 h. Purication: ash chromatog-
raphy on silica (pretreated with 1% Et3N) eluting with hexane/
EtOAc (80 : 20). Yield ¼ 203.7 mg, 79%. 1H NMR (400 MHz,
chloroform-d) d 7.70–7.50 (m, 6H), 7.54–7.44 (m, 2H), 7.43–7.34
(m, 2H), 6.78 (s, 1H), 5.27 (d, J¼ 1.5 Hz, 1H), 5.16 (s, 1H), 4.09 (p,
J ¼ 8.3 Hz, 1H), 3.92 (s, 3H), 2.02–1.94 (m, 1H), 1.72–1.57 (m,
3H), 1.46–1.25 (m, 4H). 13C NMR (101 MHz, CDCl3) d 167.73,
166.69, 154.91, 153.84, 134.49, 133.84, 132.36, 129.75, 129.44,
129.32, 128.86, 126.42, 115.29, 114.51, 113.84, 113.16, 112.52,
78.65, 77.42, 77.11, 76.79, 62.68, 60.95, 53.91, 31.00, 30.11,
22.93, 22.73. HRMS calc. for C31H25N5O3, 515.1957, found
515.1954.
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